PubRank

Carol J Fabian

Author PubWeight™ 56.18‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Exemestane for breast-cancer prevention in postmenopausal women. N Engl J Med 2011 8.19
2 Goserelin for ovarian protection during breast-cancer adjuvant chemotherapy. N Engl J Med 2015 4.53
3 Treatment and prevention of intraepithelial neoplasia: an important target for accelerated new agent development. Clin Cancer Res 2002 2.71
4 Pretest prediction of BRCA1 or BRCA2 mutation by risk counselors and the computer model BRCAPRO. J Natl Cancer Inst 2002 2.45
5 Quality of life in MAP.3 (Mammary Prevention 3): a randomized, placebo-controlled trial evaluating exemestane for prevention of breast cancer. J Clin Oncol 2014 2.25
6 Phase II study of eribulin mesylate, a halichondrin B analog, in patients with metastatic breast cancer previously treated with an anthracycline and a taxane. J Clin Oncol 2009 2.05
7 Proceedings of the international consensus conference on breast cancer risk, genetics, & risk management, April, 2007. Breast J 2009 1.48
8 Effect of vitamin D supplementation on serum 25-hydroxy vitamin D levels, joint pain, and fatigue in women starting adjuvant letrozole treatment for breast cancer. Breast Cancer Res Treat 2009 1.37
9 Outcomes of a weight loss intervention among rural breast cancer survivors. Breast Cancer Res Treat 2011 1.29
10 Proceedings of the international consensus conference on breast cancer risk, genetics, & risk management, April, 2007. Cancer 2008 1.28
11 Karyometry of breast epithelial cells acquired by random periareolar fine needle aspiration in women at high risk for breast cancer. Anal Quant Cytol Histol 2007 1.11
12 Large prospective study of ovarian cancer screening in high-risk women: CA125 cut-point defined by menopausal status. Cancer Prev Res (Phila) 2011 1.10
13 Morphologically normal-appearing mammary epithelial cells obtained from high-risk women exhibit methylation silencing of INK4a/ARF. Clin Cancer Res 2007 1.05
14 Germline BRCA mutation evaluation in a prospective triple-negative breast cancer registry: implications for hereditary breast and/or ovarian cancer syndrome testing. Breast Cancer Res Treat 2014 1.03
15 Breast cancer incidence in postmenopausal women with osteoporosis or low bone mass using arzoxifene. Breast Cancer Res Treat 2012 0.96
16 Hypermethylation of the breast cancer-associated gene 1 promoter does not predict cytologic atypia or correlate with surrogate end points of breast cancer risk. Cancer Epidemiol Biomarkers Prev 2007 0.95
17 Mammographic density does not correlate with Ki-67 expression or cytomorphology in benign breast cells obtained by random periareolar fine needle aspiration from women at high risk for breast cancer. Breast Cancer Res 2007 0.95
18 Ki-67 expression in benign breast ductal cells obtained by random periareolar fine needle aspiration. Cancer Epidemiol Biomarkers Prev 2005 0.95
19 Comparison of cytomorphology in specimens obtained by random periareolar fine needle aspiration and ductal lavage from women at high risk for development of breast cancer. Breast Cancer Res Treat 2005 0.93
20 Retinoic acid receptor-beta2 promoter methylation in random periareolar fine needle aspiration. Cancer Epidemiol Biomarkers Prev 2005 0.92
21 Failure of high risk women to produce nipple aspirate fluid does not exclude detection of cytologic atypia in random periareolar fine needle aspiration specimens. Breast Cancer Res Treat 2004 0.92
22 The relationship between vitamin D and breast cancer incidence and natural history. Curr Oncol Rep 2010 0.91
23 A prospective model of care for breast cancer rehabilitation: bone health and arthralgias. Cancer 2012 0.91
24 Characterization of a preclinical model of simultaneous breast and ovarian cancer progression. Carcinogenesis 2006 0.91
25 Patient satisfaction of BRCA1/2 genetic testing by women at high risk for breast cancer participating in a prevention trial. Fam Cancer 2005 0.88
26 How I treat vitamin d deficiency. J Oncol Pract 2010 0.87
27 Workshop on imaging science development for cancer prevention and preemption. Cancer Biomark 2007 0.87
28 Digital image analysis of breast epithelial cells collected by random periareolar fine-needle aspirates (RPFNA) from women at high risk for breast cancer taking hormone replacement and the aromatase inhibitor, letrozole, for six months. Breast Cancer Res Treat 2009 0.87
29 Tamoxifen prevents premalignant changes of breast, but not ovarian, cancer in rats at high risk for both diseases. Cancer Prev Res (Phila) 2008 0.85
30 Future directions for postdoctoral training in cancer prevention: insights from a panel of experts. Cancer Epidemiol Biomarkers Prev 2014 0.85
31 Grading invasive ductal carcinoma of the breast: advantages of using automated proliferation index instead of mitotic count. Virchows Arch 2007 0.84
32 Detection of biomarker gene expression by real-time polymerase chain reaction using amplified ribonucleic acids from formalin-fixed random periareolar fine needle aspirates of human breast tissue. Anal Quant Cytol Histol 2006 0.82
33 Ductal lavage for early detection--what doesn't come out in the wash. J Natl Cancer Inst 2004 0.82
34 Assessment of RNA in human breast tissue sampled by random periareolar fine needle aspiration and ductal lavage and processed as fixed or frozen specimens. Reprod Biol 2013 0.81
35 Estrogen receptor expression in benign breast ductal cells obtained from random periareolar fine needle aspiration correlates with menopausal status and cytomorphology index score. Breast Cancer Res Treat 2006 0.80
36 Impact of neoadjuvant chemotherapy on axillary nodal involvement in patients with clinically node negative triple negative breast cancer. J Surg Oncol 2014 0.80
37 Factors associated with success of the extreme drug resistance assay in primary breast cancer specimens. Breast Cancer Res Treat 2002 0.79
38 Low-dose tamoxifen for combination hormone replacement therapy users. J Clin Oncol 2007 0.78
39 Adiponectin: a risk biomarker and attractive target for chemoprevention. J Clin Oncol 2011 0.78
40 Surrogate response biomarkers in prevention research: do they point the way or lead us astray? J Clin Oncol 2009 0.78
41 Is there a future for ductal lavage? Clin Cancer Res 2007 0.78
42 Optimization of estrogen receptor analysis by immunocytochemistry in random periareolar fine-needle aspiration samples of breast tissue processed as thin-layer preparations. Appl Immunohistochem Mol Morphol 2006 0.77
43 Effects of Flaxseed Lignan Secoisolariciresinol Diglucosideon Preneoplastic Biomarkers of Cancer Progression in a Model of Simultaneous Breast and Ovarian Cancer Development. Nutr Cancer 2015 0.76
44 Ki-67 expression in benign breast ductal cells obtained by random periareolar fine needle aspiration. Cancer Epidemiol Biomarkers Prev 2005 0.75